BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maury G. The Enantioselectivity of Enzymes Involved in Current Antiviral Therapy Using Nucleoside Analogues: A New Strategy? Antivir Chem Chemother 2000;11:165-89. [DOI: 10.1177/095632020001100301] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Miralles-llumà R, Figueras A, Busqué F, Alvarez-larena A, Balzarini J, Figueredo M, Font J, Alibés R, Maréchal J. Synthesis, Antiviral Evaluation, and Computational Studies of Cyclobutane and Cyclobutene L -Nucleoside Analogues: Cyclobutane and Cyclobutene L -Nucleoside Analogues. Eur J Org Chem 2013;2013:7761-75. [DOI: 10.1002/ejoc.201301097] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
2 Varga A, Chaloin L, Sági G, Sendula R, Gráczer E, Liliom K, Závodszky P, Lionne C, Vas M. Nucleotide promiscuity of 3-phosphoglycerate kinase is in focus: implications for the design of better anti-HIV analogues. Mol Biosyst 2011;7:1863-73. [PMID: 21505655 DOI: 10.1039/c1mb05051f] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
3 Sabini E, Hazra S, Konrad M, Lavie A. Nonenantioselectivity property of human deoxycytidine kinase explained by structures of the enzyme in complex with L- and D-nucleosides. J Med Chem 2007;50:3004-14. [PMID: 17530837 DOI: 10.1021/jm0700215] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
4 Mathé C, Gosselin G. l-Nucleoside enantiomers as antivirals drugs: A mini-review. Antiviral Research 2006;71:276-81. [DOI: 10.1016/j.antiviral.2006.04.017] [Cited by in Crossref: 151] [Cited by in F6Publishing: 127] [Article Influence: 10.1] [Reference Citation Analysis]
5 Shu CJ, Campbell DO, Lee JT, Tran AQ, Wengrod JC, Witte ON, Phelps ME, Satyamurthy N, Czernin J, Radu CG. Novel PET probes specific for deoxycytidine kinase. J Nucl Med 2010;51:1092-8. [PMID: 20554721 DOI: 10.2967/jnumed.109.073361] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
6 Nascimento-Júnior NM, Kümmerle AE, Barreiro EJ, Fraga CA. MAOS and medicinal chemistry: some important examples from the last years. Molecules 2011;16:9274-97. [PMID: 22064269 DOI: 10.3390/molecules16119274] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
7 Popsavin V, Krstić I, Popsavin M, Srećo B, Benedeković G, Kojić V, Bogdanović G. Enantiodivergent synthesis of muricatacin related lactones from d-xylose based on the latent symmetry concept: preparation of two novel cytotoxic (+)- and (−)-muricatacin 7-oxa analogs. Tetrahedron 2006;62:11044-53. [DOI: 10.1016/j.tet.2006.09.054] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
8 D'alonzo D, Guaragna A. Stereoselective Methods in the Synthesis of Bioactive Oxathiolane and Dioxolane Nucleosides. In: Merino P, editor. Chemical Synthesis of Nucleoside Analogues. Hoboken: John Wiley & Sons, Inc.; 2013. pp. 727-80. [DOI: 10.1002/9781118498088.ch16] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
9 Struntz NB, Hu T, White BR, Olson ME, Harki DA. Inhibition of guanosine monophosphate synthetase by the substrate enantiomer L-XMP. Chembiochem 2012;13:2517-20. [PMID: 23097382 DOI: 10.1002/cbic.201200503] [Reference Citation Analysis]
10 Salvatori D, Vincenzetti S, Maury G, Gosselin G, Gaubert G, Vita A. Maedi-visna virus, a model for in vitro testing of potential anti-HIV drugs. Comparative Immunology, Microbiology and Infectious Diseases 2001;24:113-22. [DOI: 10.1016/s0147-9571(00)00021-7] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
11 Schwarzenberg J, Radu CG, Benz M, Fueger B, Tran AQ, Phelps ME, Witte ON, Satyamurthy N, Czernin J, Schiepers C. Human biodistribution and radiation dosimetry of novel PET probes targeting the deoxyribonucleoside salvage pathway. Eur J Nucl Med Mol Imaging 2011;38:711-21. [PMID: 21127859 DOI: 10.1007/s00259-010-1666-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
12 Kapusta K, Sizochenko N, Karabulut S, Okovytyy S, Voronkov E, Leszczynski J. QSPR modeling of optical rotation of amino acids using specific quantum chemical descriptors. J Mol Model 2018;24. [DOI: 10.1007/s00894-018-3593-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
13 Delaney WE 4th, Locarnini S, Shaw T. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation. Antivir Chem Chemother. 2001;12:1-35. [PMID: 11437320 DOI: 10.1177/095632020101200101] [Cited by in Crossref: 73] [Cited by in F6Publishing: 66] [Article Influence: 3.8] [Reference Citation Analysis]
14 Palmai Z, Perahia D, Lionne C, Fidy J, Balog E, Chaloin L. Ligand chirality effects on the dynamics of human 3-phosphoglycerate kinase: comparison between D- and L-nucleotides. Arch Biochem Biophys 2011;511:88-100. [PMID: 21549683 DOI: 10.1016/j.abb.2011.04.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
15 Alexandre JA, Roy B, Topalis D, Pochet S, Périgaud C, Deville-Bonne D. Enantioselectivity of human AMP, dTMP and UMP-CMP kinases. Nucleic Acids Res 2007;35:4895-904. [PMID: 17626051 DOI: 10.1093/nar/gkm479] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
16 Julander JG, Bowen RA, Rao JR, Day C, Shafer K, Smee DF, Morrey JD, Chu CK. Treatment of Venezuelan equine encephalitis virus infection with (-)-carbodine. Antiviral Res 2008;80:309-15. [PMID: 18675850 DOI: 10.1016/j.antiviral.2008.07.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
17 Perrone D, Capobianco ML. L -Nucleosides. In: Merino P, editor. Chemical Synthesis of Nucleoside Analogues. Hoboken: John Wiley & Sons, Inc.; 2013. pp. 473-534. [DOI: 10.1002/9781118498088.ch11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
18 Pasti C, Gallois-Montbrun S, Munier-Lehmann H, Veron M, Gilles AM, Deville-Bonne D. Reaction of human UMP-CMP kinase with natural and analog substrates. Eur J Biochem 2003;270:1784-90. [PMID: 12694191 DOI: 10.1046/j.1432-1033.2003.03537.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
19 Roy B, Verri A, Lossani A, Spadari S, Focher F, Aubertin A, Gosselin G, Mathé C, Périgaud C. Enantioselectivity of ribonucleotide reductase: a first study using stereoisomers of pyrimidine 2′-azido-2′-deoxynucleosides. Biochemical Pharmacology 2004;68:711-8. [DOI: 10.1016/j.bcp.2004.05.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
20 Skorobogatyi MV, Pchelintseva AA, Petrunina AL, Stepanova IA, Andronova VL, Galegov GA, Malakhov AD, Korshun VA. 5-Alkynyl-2′-deoxyuridines, containing bulky aryl groups: evaluation of structure–anti-HSV-1 activity relationship. Tetrahedron 2006;62:1279-87. [DOI: 10.1016/j.tet.2005.10.057] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
21 Sabini E, Hazra S, Konrad M, Burley SK, Lavie A. Structural basis for activation of the therapeutic L-nucleoside analogs 3TC and troxacitabine by human deoxycytidine kinase. Nucleic Acids Res 2007;35:186-92. [PMID: 17158155 DOI: 10.1093/nar/gkl1038] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
22 Pejanović V, Stokić Z, Stojanović B, Piperski V, Popsavin M, Popsavin V. Synthesis and biological evaluation of some novel 4′-Thio-l-ribonucleosides with modified nucleobase moieties. Bioorganic & Medicinal Chemistry Letters 2003;13:1849-52. [DOI: 10.1016/s0960-894x(03)00289-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
23 Zhang HW, Detorio M, Herman BD, Solomon S, Bassit L, Nettles JH, Obikhod A, Tao SJ, Mellors JW, Sluis-Cremer N, Coats SJ, Schinazi RF. Synthesis, antiviral activity, cytotoxicity and cellular pharmacology of l-3'-azido-2',3'-dideoxypurine nucleosides. Eur J Med Chem 2011;46:3832-44. [PMID: 21700368 DOI: 10.1016/j.ejmech.2011.05.051] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
24 Bzowska A, Kulikowska E, Shugar D. Purine nucleoside phosphorylases: properties, functions, and clinical aspects. Pharmacology & Therapeutics 2000;88:349-425. [DOI: 10.1016/s0163-7258(00)00097-8] [Cited by in Crossref: 322] [Cited by in F6Publishing: 72] [Article Influence: 15.3] [Reference Citation Analysis]
25 Gallois-Montbrun S, Faraj A, Seclaman E, Sommadossi JP, Deville-Bonne D, Véron M. Broad specificity of human phosphoglycerate kinase for antiviral nucleoside analogs. Biochem Pharmacol 2004;68:1749-56. [PMID: 15450940 DOI: 10.1016/j.bcp.2004.06.012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
26 Eriksson S, Wang L. The Role of the Cellular Deoxynucleoside Kinases in Activation of Nucleoside Analogs Used in Chemotherapy. Recent Advances in Nucleosides: Chemistry and Chemotherapy. Elsevier; 2002. pp. 455-75. [DOI: 10.1016/b978-044450951-2/50016-3] [Cited by in Crossref: 7] [Article Influence: 0.4] [Reference Citation Analysis]
27 He J, Roy B, Périgaud C, Kashlan OB, Cooperman BS. The enantioselectivities of the active and allosteric sites of mammalian ribonucleotide reductase. FEBS J 2005;272:1236-42. [PMID: 15720397 DOI: 10.1111/j.1742-4658.2005.04557.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]